Imaging Biomarkers in clinical trials: Focus on Oncology

Friday, April 26 – Saturday, April 27 2013
1:00 pm – 5:00 pm

This event was posted by Partners HealthCare System, Inc.

Location: O'keefe Auditorium, Mass General Hospital, Boston MA

Imaging biomarkers serve as important endpoints for clinical trials in the approval process for therapeutic drugs. Various criteria have been developed for objective interpretation of imaging studies. Additionally, there are emerging imaging techniques that have the potential for applications as surrogate endpoints for clinical trials.

In this program, we will review the current practice of imaging biomarkers in clinical trials in oncology. Additionally, we will highlight advanced imaging techniques that have potential as surrogate biomarkers.

Share MassBio

 

 

MassBio Golf Classic

BioProcess

EvaluatePharma